Bio-Techne Reports Q1 FY2026 Financial Results
Slice of Healthcare Team
11/06/2025
Key highlights
- Revenue decreased 1% to $286.6 million.
- GAAP EPS increased to $0.24.
- Adjusted operating margin rose to 29.9%.
- Divestiture of Exosome Diagnostics completed.
- Strong performance from ProteinSimple and Cell Therapy.
Source: PR Newswire
Notable Quote
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
